Rausch, Steffen
Schollenberger, Daniel
Hennenlotter, Joerg
Stühler, Viktoria
Kruck, Stephan
Stenzl, Arnulf
Bedke, Jens
Funding for this research was provided by:
Novartis Pharma (SAFI-019)
Article History
Received: 18 May 2018
Accepted: 19 October 2018
First Online: 27 October 2018
Compliance with ethical standards
:
: JB: consultancies, honoraria or study participation from Bayer, BMS, Eisai, Eusa, Immatics, Ipsen, Novartis, Pfizer and Roche. AS: consultancies, honoraria or study participation from Bayer, BMS, Eisai, Immatics, Ipsen, Novartis, Pfizer and Roche.
: The study was approved by the institutional review board and conducted in accordance with the Helsinki and START protocol. We take responsibility to the integrity of the data and accuracy of the reported study. All authors have made a substantial contribution to the information or material submitted for publication and approved the final version.